Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 354

1.

Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.

Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi TK, Hattori T.

Mod Pathol. 2002 Apr;15(4):397-405.

2.
3.

The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.

Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, Law BK, Lam WW.

J Clin Pathol. 2007 Mar;60(3):315-20. Epub 2006 May 12.

4.

Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.

Popnikolov NK, Cavone SM, Schultz PM, Garcia FU.

Mod Pathol. 2005 Dec;18(12):1535-41.

5.

Immunoreactivity of ductal cells with putative myoepithelial markers: A potential pitfall in breast carcinoma.

Nayar R, Breland C, Bedrossian U, Masood S, DeFrias D, Bedrossian CW.

Ann Diagn Pathol. 1999 Jun;3(3):165-73.

PMID:
10359852
6.
7.
8.

Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.

Bier B, Douglas-Jones A, Tötsch M, Dockhorn-Dworniczak B, Böcker W, Jasani B, Schmid KW.

Breast Cancer Res Treat. 1994;30(3):213-21.

PMID:
7981441
9.

p63 and CD10: reliable markers in discriminating benign sclerosing lesions from tubular carcinoma of the breast?

de Moraes Schenka NG, Schenka AA, de Souza Queiroz L, de Almeida Matsura M, Alvarenga M, Vassallo J.

Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):71-7.

PMID:
16540734
10.

Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast.

Prasad ML, Hyjek E, Giri DD, Ying L, O'Leary JJ, Hoda SA.

Am J Surg Pathol. 1999 Feb;23(2):176-81.

PMID:
9989844
12.

Use of a novel marker, calponin, for myoepithelial cells in fine-needle aspirates of papillary breast lesions.

Mosunjac MB, Lewis MM, Lawson D, Cohen C.

Diagn Cytopathol. 2000 Sep;23(3):151-5.

PMID:
10945900
13.
14.

Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.

Pavlakis K, Zoubouli C, Liakakos T, Messini I, Keramopoullos A, Athanassiadou S, Kafousi M, Stathopoulos EN.

Breast. 2006 Dec;15(6):705-12. Epub 2005 Dec 27.

PMID:
16384708
15.

Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept.

Böcker W, Moll R, Poremba C, Holland R, Van Diest PJ, Dervan P, Bürger H, Wai D, Ina Diallo R, Brandt B, Herbst H, Schmidt A, Lerch MM, Buchwallow IB.

Lab Invest. 2002 Jun;82(6):737-46.

PMID:
12065684
16.
17.

Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.

Kuroda N, Jin YL, Hamauzu T, Toi M, Miyazaki E, Hiroi M, Moriki T, Enzan H.

Histol Histopathol. 2005 Jul;20(3):707-12.

PMID:
15944918
18.

Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study.

Damiani S, Ludvikova M, Tomasic G, Bianchi S, Gown AM, Eusebi V.

Virchows Arch. 1999 Mar;434(3):227-34.

PMID:
10190302
19.

The value of p63 and CK5/6 expression in the differential diagnosis of ductal lesions of breast.

Ding Y, Ruan Q.

J Huazhong Univ Sci Technolog Med Sci. 2006;26(4):405-7.

PMID:
17120733
20.
Items per page

Supplemental Content

Write to the Help Desk